Caveolin-1 opens endothelial cell junctions by targeting catenins

Cardiovascular Research

Volumn 93, Issue 1, 2012, Pages 130-140

  Kronstein, Romy ^a   Seebach, Jochen ^b   Großklaus, Sylvia ^a   Minten, Carsten ^c   Engelhardt, Britta ^c   Drab, Marek ^d   Liebner, Stefan ^e   Arsenijevic, Yvan ^f   Taha, Abdallah Abu ^b   Afanasieva, Tatiana ^a   Schnittler, Hans Joachim ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^e GOETHE UNIVERSITY   (Germany)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

catenin; Caveolin 1; Impedance spectroscopy; Permeability; VE cadherin

Indexed keywords

BETA CATENIN; CAVEOLIN 1; PLAKOGLOBIN; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ARTICLE; BIOCHEMISTRY; CELL CULTURE; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; CADHERINS; CATENINS; CAVEOLIN 1; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DNA PRIMERS; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR JUNCTIONS; MICE; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; MUTANT PROTEINS; THROMBIN;

EID: 84555186826     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr256     Document Type: Article

References (43)

1. Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009;16:209-221.
2. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008;28: 223-232. (Pubitemid 351161193)
3. Pokutta S, Weis WI. Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu Rev Cell Dev Biol 2007;23:237-261.
4. Abe K, Takeichi M. EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc Natl Acad Sci USA 2008;105:13-19.
5. Seebach J, Donnert G, Kronstein R, Werth S, Wojciak-Stothard B, Falzarano D et al. Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype. Cardiovasc Res 2007;75:596-607. (Pubitemid 47080968)
6. Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem 2002;277: 41295-41298. (Pubitemid 35257426)
7. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007;8: 185-194.
8. Bauer PM, Yu J, Chen Y, Hickey R, Bernatchez PN, Looft-Wilson R et al. Endothelialspecific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci USA 2005;102:204-209. (Pubitemid 40094453)
9. Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem 2001;276:48619-48622.
10. Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA et al. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am J Pathol 2003;162:2059-2068. (Pubitemid 36613061)
11. Millan J, Hewlett L, Glyn M, Toomre D, Clark P, Ridley AJ. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola-and F-actin-rich domains. Nat Cell Biol 2006;8:113-123.
12. Song L, Ge S, Pachter JS. Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood 2007;109:1515-1523. (Pubitemid 46239584)
13. Sun Y, Hu G, Zhang X, Minshall RD. Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ Res 2009;105:676-685.
14. Chang SH, Feng D, Nagy JA, Sciuto TE, Dvorak AM, Dvorak HF. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol 2009;175: 1768-1776.
15. Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze'ev A, Pestell RG et al. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting betacatenin to caveolae membrane domains. J Biol Chem 2000;275:23368-23377. (Pubitemid 30646240)
16. Mo S, Wang L, Li Q, Li J, Li Y, Thannickal VJ et al. Caveolin-1 regulates dorsoventral patterning through direct interaction with beta-catenin in zebrafish. Dev Biol 2010; 344:210-223.
17. Schnittler HJ, Puschel B, Drenckhahn D. Role of cadherins and plakoglobin in interendothelial adhesion under resting conditions and shear stress. Am J Physiol 1997; 273:H2396-H2405.
18. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G et al. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002;21:4885-4895.
19. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001;293:2449-2452. (Pubitemid 32917325)
20. Reiss Y, Hoch G, Deutsch U, Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur J Immunol 1998;28:3086-3099. (Pubitemid 28470254)
21. Cattelino A, Liebner S, Gallini R, Zanetti A, Balconi G, Corsi A et al. The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 2003;162:1111-1122. (Pubitemid 37174193)
22. Pokutta S, Weis WI. Structure of the dimerization and beta-catenin-binding region of alpha-catenin. Mol Cell 2000;5:533-543.
23. Schwencke C, Schmeisser A, Walter C, Wachter R, Pannach S, Weck B et al. Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis. Cardiovasc Res 2005;68:128-135. (Pubitemid 41253563)
24. Butz S, Stappert J, Weissig H, Kemler R. Plakoglobin and beta-catenin: distinct but closely related letter]. Science 1992;257:1142-1144.
25. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272: 263-267. (Pubitemid 26119138)
26. Dieckmann-Schuppert A, Schnittler HJ. A simple assay for quantification of protein in tissue sections, cell cultures, and cell homogenates, and of protein immobilized on solid surfaces. Cell Tissue Res 1997;288:119-126. (Pubitemid 27136150)
27. Wong CW, Wiedle G, Ballestrem C, Wehrle-Haller B, Etteldorf S, Bruckner M et al. PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis In Process Citation]. Mol Biol Cell 2000;11:3109-3121. (Pubitemid 32107087)
28. Ilan N, Cheung L, Pinter E, Madri JA. Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem 2000;275:21435-21443. (Pubitemid 30481846)
29. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J et al. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endotheliumspecific cadherin. Arterioscler Thromb Vasc Biol 1995;15:1229-1239.
30. Bogatcheva NV, Garcia JG, Verin AD. Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc) 2002;67:75-84.
31. Cao H, Courchesne WE, Mastick CC. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14 recruitment of C-terminal Src kinase. J Biol Chem 2002;277:8771-8774. (Pubitemid 34952941)
32. Li S, Couet J, Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 1996;271: 29182-29190. (Pubitemid 26382628)
33. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 2010;103: 40-55.
34. Hu G, Place AT, Minshall RD. Regulation of endothelial permeability by Src kinase signaling: Vascular leakage versus transcellular transport of drugs and macromolecules. Chem Biol Interact 2008;171:177-89.
35. Schnittler HJ, Wilke A, Gress T, Suttorp N, Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol (Lond) 1990;431:379-401.
36. Wysolmerski RB, Lagunoff D. Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci USA 1990;87:16-20.
37. Patton WF, Dhanak MR, Jacobson BS. Differential partitioning of plasma membrane proteins into the triton X-100-insoluble cytoskeleton fraction during concanavalin A-induced receptor redistribution. J Cell Sci 1989;92(Pt 1):85-91. (Pubitemid 19046860)
38. Biswas P, Canosa S, Schoenfeld D, Schoenfeld J, Li P, Cheas LC et al. PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. Am J Pathol 2006; 169:314-324.
39. Stahlhut M, van Deurs B. Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell 2000;11:325-337. (Pubitemid 30075526)
40. Russo A, Soh UJ, Paing MM, Arora P, Trejo J. Caveolae are required for proteaseselective signaling by protease-activated receptor-1. Proc Natl Acad Sci USA 2009; 106:6393-6397.
41. Beckers CM, Garcia-Vallejo JJ, van Hinsbergh VW, van Nieuw Amerongen GP. Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res 2008;79:679-688.
42. Guo M, Breslin JW, Wu MH, Gottardi CJ, Yuan SY. VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Am J Physiol Cell Physiol 2008;294:C977-C984. (Pubitemid 351507915)
43. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C et al. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 2008;205:2929-2945.